JNK1 ligand-1 (Compound P1) is a selective JNK1 inhibitor. JNK1 ligand-1 can be used as a JNK1 ligand to synthesize a series of PROTAC molecules, such as PROTAC JNK1-targeted-1. PROTAC JNK1-targeted-1 can be used for the research of pulmonary fibrosis [1].
In Vitro, PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
References:
[1]. Guo Y, et al. Design and synthesis of JNK1-targeted PROTACs and research on the activity. Bioorg Chem. 2025 Jan;154:108044.
In Vitro, PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
References:
[1]. Guo Y, et al. Design and synthesis of JNK1-targeted PROTACs and research on the activity. Bioorg Chem. 2025 Jan;154:108044.